Immunoreactive atrial natriuretic factor (IR-ANF) in human plasma

Area of Science:

• Cardiovascular Physiology
• Endocrinology
• Biochemical Assays

Background:

• Atrial natriuretic factor (ANF) is a hormone with significant cardiovascular effects.
• Accurate quantification of ANF in human plasma is crucial for understanding its physiological roles and related pathologies.
• Existing methods for ANF measurement may lack sensitivity or specificity.

Purpose of the Study:

• To develop and validate a direct radioimmunoassay (RIA) for quantifying immunoreactive ANF (IR-ANF) in human plasma.
• To establish the normal concentration range of IR-ANF in healthy individuals.
• To investigate changes in circulating IR-ANF levels under specific physiological stimuli.

Main Methods:

• Development of a direct radioimmunoassay using synthetic alpha-human atrial peptide (Ser 99-Tyr 126) for tracer and standard preparation.
• Assay validation, including determination of sensitivity (1.9 pg/ml).
• Measurement of IR-ANF in plasma from 59 healthy subjects and in patients undergoing atrial pacing; plasma extraction and purification using Vycor glass and HPLC.

Main Results:

• The developed RIA demonstrated a sensitivity of 1.9 pg/ml.
• Mean plasma IR-ANF concentration in 59 healthy subjects was 65.3 +/- 2.5 pg/ml.
• Atrial pacing in two patients resulted in an approximate 100% increase in circulating IR-ANF.
• Purification of IR-ANF from plasma revealed a main immunoreactive peak containing a low molecular weight peptide.

Conclusions:

• A sensitive and direct radioimmunoassay for human plasma ANF has been successfully developed.
• The assay provides a reliable method for assessing ANF levels in clinical and research settings.
• Elevated ANF levels during atrial pacing suggest its rapid response to changes in atrial pressure or volume, highlighting its role in cardiovascular homeostasis.